This was the stock's third consecutive day of losses.

Japan’s boom in management buyouts looks set for stricter oversight to protect minority shareholders when companies go ...

This was the stock's second consecutive day of gains.

The increasing global prevalence of cancer is fueling the demand for peptide-drug conjugates as targeted therapies, providing improved effectiveness and lower systemic toxicity than conventional ...

Space company Rocket Lab USA (NASDAQ: RKLB) enjoyed a modest stock price bump in early trading on the Nasdaq Tuesday, rising ...

Amgen stock skidded late Tuesday after the biotech behemoth said the FDA placed one of its obesity treatments on clinical ...

The upcoming Jurassic World Rebirth is going to be a fresh start for the Jurassic Park franchise, but its roots are buried ...